BioNexus Gene Lab Corp. (BGLC)
1.19
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
1.16
-0.03
(-2.52%)
Pre-Market: 20:00
BioNexus Gene Lab Enterprise Value : -0.4463M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -0.4463M |
| October 22, 2026 | -0.4463M |
| October 21, 2026 | -0.4463M |
| October 20, 2026 | -0.4101M |
| October 19, 2026 | -0.3547M |
| October 16, 2026 | -0.4195M |
| October 15, 2026 | -0.3714M |
| October 14, 2026 | -0.2771M |
| October 13, 2026 | -0.1321M |
| October 12, 2026 | 0.0362M |
| October 09, 2026 | -0.2046M |
| October 08, 2026 | -0.303M |
| October 07, 2026 | -0.0837M |
| October 06, 2026 | -0.3254M |
| October 05, 2026 | -0.2288M |
| October 02, 2026 | -0.2529M |
| October 01, 2026 | -0.4221M |
| September 30, 2026 | -0.3738M |
| September 29, 2026 | -0.2529M |
| September 28, 2026 | -0.1804M |
| September 25, 2026 | 0.0371M |
| September 24, 2026 | 0.2547M |
| September 23, 2026 | 0.2305M |
| September 22, 2026 | 0.2064M |
| September 21, 2026 | 0.303M |
| Date | Value |
|---|---|
| September 18, 2026 | 0.4723M |
| September 17, 2026 | 0.2426M |
| September 16, 2026 | 0.2547M |
| September 15, 2026 | 0.158M |
| September 14, 2026 | 0.303M |
| September 11, 2026 | 0.569M |
| September 10, 2026 | 0.2547M |
| September 09, 2026 | 0.1822M |
| September 08, 2026 | 0.0613M |
| September 04, 2026 | 0.1822M |
| September 03, 2026 | 0.2305M |
| September 02, 2026 | 0.2305M |
| September 01, 2026 | 0.2305M |
| August 31, 2026 | 0.2789M |
| August 28, 2026 | 0.4239M |
| August 27, 2026 | 0.303M |
| August 26, 2026 | 0.1338M |
| August 25, 2026 | 0.4239M |
| August 24, 2026 | 0.4239M |
| August 21, 2026 | 0.5206M |
| August 20, 2026 | 0.5121M |
| August 19, 2026 | 0.4723M |
| August 18, 2026 | 0.3997M |
| August 17, 2026 | 0.5233M |
| August 14, 2026 | 0.4723M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intertek Group Plc | -- |
| ALS Ltd. | -- |
| NEXT-ChemX Corp. | -- |
| Capital A Bhd. | 574.21M |
| AECOM | 10.31B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2865M |
| Revenue (Quarterly) | 0.0762M |
| Total Expenses (Quarterly) | 0.3626M |
| EPS Diluted (Quarterly) | -0.1185 |
| Gross Profit Margin (Quarterly) | 17.06% |
| Profit Margin (Quarterly) | -376.0% |
| Earnings Yield | -106.0% |
| Normalized Earnings Yield | -105.88 |